February 22, 2017 / 2:25 PM / 7 months ago

BRIEF-VBI Vaccines receives positive response from Health Canada's initial evaluation of the proposed Sci-B-Vac Phase III clinical program

Feb 22 (Reuters) - VBI Vaccines Inc

* VBI Vaccines receives positive response from Health Canada’s initial evaluation of the proposed Sci-B-Vac Phase III clinical program

* VBI Vaccines Inc - positive response from Health Canada enables us to submit formal CTA to Health Canada in first half of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below